HK Stock Market Move | METIS TECHBIO-P(07666) continues to rise, with a cumulative increase of over 20% in the past five trading days. Join hands with Deerfield to jointly develop AI-driven protein drugs and in vivo immunotherapy.

METIS TECHBIO-P (07666) rose more than 3% during trading hours, with a cumulative increase of over 20% in the past five trading days, and its total market value has exceeded HK$17 billion. In terms of news, Jitai Technology recently announced a strategic alliance with Deerfield, a top global health investment and innovation platform. The strategic alliance aims to deeply integrate Jitai Technology's proprietary differentiated technology in AI-driven protein engineering, in vivo immunotherapy, and programmable biologics with Deerfield's deep industry experience and professional capabilities in translational medicine, clinical development, healthcare innovation, and global collaboration. It is reported that Deerfield will deepen cooperation on global clinical development and business expansion initiatives related to Jitai Technology's self-developed AI nanodelivery platform NanoForge and its core pipeline projects, including a leading T cell engager (TCE) project discovered and advanced to the preclinical candidate stage on Jitai Technology's self-developed AiProtein platform. Deerfield will further explore potential licensing and development opportunities for this project to advance it to the IND-supporting research and clinical development stages.